Fuji Pharma Co., Ltd. (TYO:4554)

Market Cap	46.24B
Revenue (ttm)	51.68B
Net Income (ttm)	3.00B
Shares Out	24.46M
EPS (ttm)	122.93
PE Ratio	15.38
Forward PE	12.42
Dividend	47.00 (2.47%)
Ex-Dividend Date	Mar 30, 2026

Volume	55,300
Average Volume	79,760
Open	1,899.00
Previous Close	1,900.00
Day's Range	1,863.00 - 1,903.00
52-Week Range	1,180.00 - 1,938.00
Beta	0.29
RSI	57.07
Earnings Date	Feb 5, 2026

About Fuji Pharma

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 1,760
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4554

Financial Performance

In 2025, Fuji Pharma's revenue was 51.68 billion, an increase of 12.01% compared to the previous year's 46.14 billion. Earnings were 3.00 billion, a decrease of -51.19%.